5-MeO-DiPT vesinikkloriid
5-MeO-DiPT vesinikkloriid Hinnavahemik: €23.50 kuni €336.00
Tagasi toodete juurde
EPT fumaraat (N-etüül-N-propüültrüptamiin)
EPT fumaraat (N-etüül-N-propüültrüptamiin) Hinnavahemik: €23.50 kuni €336.00
5-MeO-DMT freebase - Pilt 1
5-MeO-DMT freebase - Pilt 2

5-MeO-DMT vaba alus

5-MeO-DMT vaba aluse omadused

Sünonüüm: 5-metoksü-N,N-dimetüültrüptamiin
CAS-number: 1019-45-0
Valem: 3-[2-(dimetüülamino)etüül]-5-metoksüindool
Molaarmass: 218,3 g/mol
Puhtus: >97%

Hinnavahemik: €25.00 kuni €700.00

Lisa võrdlusse
Lisa soovinimekirja
SÄÄSTA 15%

veel 2 toodet

SÄÄSTA 50%

6 tk 3 hinnaga

* Sellel lehel olev teave on kokkuvõte ega ole mõeldud hõlmama kogu selle ravimi kohta kättesaadavat teavet. See ei hõlma kõiki võimalikke kasutusviise, juhiseid, ettevaatusabinõusid, ravimite koostoimeid ega kõrvaltoimeid ning ei asenda teie tervishoiutöötaja teadmisi ja hinnanguid.

5-MeO-DMT Freebase – Scientific Product Documentation

General Description

5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine) freebase is a naturally occurring tryptamine with a potent psychoactive profile, found in various plants and animal secretions. In its freebase form, it offers superior volatility for certain research methods, making it valuable for pharmacological and neuroscience studies.

Tehnilised andmed

ParameeterSpetsifikatsioon
Chemical FormulaC₁₃H₁₈N₂O
Molecular Weight218,29 g/mol
Puhtus≥98% (HPLC-UV analyzed)
VormCrystalline/white powder
LahustuvusSoluble in organic solvents (ethanol, methanol, DMSO), limited in water
Sulamistemperatuur60–65 °C (vaba alus)
StabiilsusLight and oxygen sensitive; store under inert gas

Teaduslikud rakendused

1. Neuropharmacological Research

  • Serotonergic Action:  Potent 5-HT₁ₐ/₂ₐ agonist, relevant for studies of consciousness modulation.

  • EEG/fMRI studies:  Investigation of acute effects on brain wave patterns (e.g. gamma oscillations).

  • Neuroplasticity:  Possible BDNF-enhancing effects (in animal models).

2. Metabolic & Toxicological Studies

  • MAO-dependent metabolism:  Investigation of CYP2D6 and MAO-A degradation pathways.

  • Dose-dependent toxicity:  Determination of safety margins in cell cultures.

3. Comparative Pharmacology

  • Compared to DMT:  Higher potency but shorter duration of action (15-30 min when inhaled).

  • Compared to psilocybin:  Differences in receptor affinity and subjective effects.

Experimental Guidelines

Recommended Concentrations (In Vitro)

TaotlusConcentration rangeLahusti
Retseptori sidumise testid1 nM – 10 µMPBS/DMSO (≤0,1%)
Cell culture experiments0,1–100 µMDMEM/FBS
Gas chromatography1 mg/ml (metanoolis)Metanool (HPLC-kvaliteediga)

Safety protocols

  • Personal Protection:  Lab coat, nitrile gloves, safety glasses, FFP2 mask when handling powder.

  • Ventilation:  Always work under a fume cupboard when heating/evaporating.

  • Säilitamine:  In amber vials, under argon, at -20°C (long term).

Stability & Storage

  • Shelf life:

    • Room temperature: <24 hours in solution.

    • 4°C: Stable for 3 days (under argon).

    • -20°C: >6 months (unchanged purity).

  • Degradation products:

    • Oxidation to indole derivatives (check by TLC/HPLC).

Analytical Certification

Each batch includes:

  1. HPLC-UV kromatogramm  (λ=280 nm, C18 column)

  2. GC-MS confirmation  (characteristic fragments: m/z 174, 160)

  3. Residual solvent analysis  (≤500 ppm)

  4. Water content  (Karl Fischer, <1%)

Legal Status (Netherlands)

  • Opium Act:  Not explicitly regulated, but possibly under analogous legislation.

  • Legislation:  A licence is required for scientific institutions (Appendix 2, Opium Act).

  • Export restrictions:  CITES listing (due to natural sources such as  Incilius alvarius ).

Korduma kippuvad küsimused (KKK)

Q1: What is the difference between freebase and fumaric acid salt?
A: Freebase is more volatile (suitable for evaporation experiments), while fumaric acid salt is more stable in solutions.

Q2: How is 5-MeO-DFT detected in toxicology screens?
A: Identifiable by:

  • LC-MS/MS (eelkäsiooni m/z 219 → produktiooni m/z 174)

  • Immunoassays: Cross-reactivity with some DMT tests (≤30%).

Q3: Are there any known pharmacokinetic interactions?
V:  Dangerous combinations:

  • MAO inhibitors (risk of serotonin syndrome).

  • SSRIs (reduced efficacy due to competition).

Q4: How to dispose of waste?
A: Inactivate with:

  1. Dilute hydrochloric acid (0.1M) for neutralization.

  2. Absorption with activated carbon.

  3. Dispose of as  hazardous chemical waste  (UN number: 3249).

References & Contact

Key publications:

  • Szára, S. (2007). "DMT ja 5-MeO-DMT: varajased inimuuringud".

  • Uthaug et al. (2021). "5-MeO-DMT psühhofarmakoloogia".

This product is intended solely for legitimate scientific research. Not for human or veterinary use. Users must comply with all local regulations.